why choose us

Clinical Trials Search

Showing 10,110 of 132,963 result(s)
Caregiver Skills Training: Comparing Clinician Training Methods

Status: Completed

Condition: Parenting

Interventions: The investigators are comparing the relative efficacy of CST between a CST group led by clinicians trained and supervised remotely versus a group led

Date: 2023-07-19

DFC 004 Biomarkers for Active Diabetic Foot Ulcers

Status: Completed

Condition: Diabetic Foot Ulcer

Interventions:

Date: 2023-07-19

Donor-Derived Anti-CD33 CAR T Cell Therapy (VCAR33) in Patients With Relapsed or Refractory AML After Allogeneic Hematopoietic Cell Transplant

Status: Completed

Condition: Leukemia, Myeloid, Acute

Interventions: Allogeneic Anti-CD33 Chimeric Antigen Receptor (CAR) T Cell therapy

Date: 2023-07-19

A Study to Investigate Effect of Clarithromycin, a Strong CYP3A4 Inhibitor, on Brensocatib Pharmacokinetics in Healthy Participants

Status: COMPLETED

Condition: Healthy Volunteers

Interventions: Oral tablets.

Date: 2023-07-19

Comparison of Local Anesthetic Dose in Ipack Block Performed in Knee Arthroplasty Operations

Status: COMPLETED

Condition: Analgesia

Interventions: US guided IPACK block will be performed with 10;15;20 ml %0,25 bupivacaine and adductor block will be performed with 15 ml %0,25 bupivacaine

Date: 2023-07-19

PBM or Dry Float Therapy on Sleep Quality in Middle-aged and Elderly

Status: COMPLETED

Condition: Sleep Quality

Interventions: Following the baseline block (first four weeks), participants will use the NovoThor device 2-3 times per week for 20 minute sessions at the WVU Rockef

Date: 2023-07-19

New Microprocessor-Controlled Prosthetic Knee Evaluation

Status: COMPLETED

Condition: Lower Limb Amputation Above Knee (Injury)

Interventions: The subject will wear the microprocessor-controlled knee prosthesis for 4 weeks, and then reply questionnaires and achieve functional tests

Date: 2023-07-19

A Phase 1;2 Study of Anvumetostat in Combination With IDE397 in Participants With Advanced Methylthioadenosine Phosphorylase (MTAP)-Null Solid Tumors

Status: COMPLETED

Condition: MTAP-null Non-Small-Cell Lung Cancer

Interventions: Administered PO

Date: 2023-07-19

De-novo Initiation of Letermovir vs Valganciclovir for Cytomegalovirus Prophylaxis in AA Kidney Transplant Recipients

Status: COMPLETED

Condition: Kidney Transplant; Complications
CMV

Interventions: DRUG: Letermovir 480 mg once daily - We will test the study hypothesis in a single center, matched (1:1 fashion) pilot study of Letermovir 480 mg once

Date: 2023-07-18

Time Course Change in Skeletal Muscle and Blood Phospholipid Composition with Omega-3 Fatty Acid Supplementation

Status: COMPLETED

Condition: Skeletal Muscle Fatty Acid Metabolism

Interventions: Participants in this group will receive 5g fish oil with high EPA and DHA content per day

Date: 2023-07-18